Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Prostate Cancer and Prostatic Diseases|June 2, 2025
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional seriesLeonardo Quarta, Armando Stabile, Francesco Pellegrino, et al.
Clinical Genitourinary Cancer|November 7, 2024
Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder CancerPietro Scilipoti, Marco Moschini, Mario de Angelis, et al.
World Journal of Urology|November 6, 2024
The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancerPietro Scilipoti, Marco Moschini, Mario de Angelis, et al.
Clinical Genitourinary Cancer|June 13, 2025
Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical CystectomyPietro Scilipoti, Marco Moschini, Paolo Zaurito, et al.
Prostate Cancer and Prostatic Diseases|May 2, 2026
Clinical and surgical management of recto-urinary fistula after radical prostatectomy: a systematic review on current evidenceMario de Angelis, Pietro Scilipoti, Riccardo Leni, et al.
European Urology Oncology|May 12, 2026
Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPaolo Zaurito, Pietro Scilipoti, Alfonso Santangelo, et al.
European Urology Oncology|February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological OutcomesMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International|May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre studyMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International|January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group resultsPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
BJU International|March 26, 2025
The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidatesMario de Angelis, Pietro Scilipoti, Alfonso Santangelo, et al.
Pageof 5